SUNPHARMA had a strong weekly performance, returning 2.47% and outperforming its peers, with a relatively low volatility of 25.17%. The stock's Sharpe Ratio of 0.39 indicates a moderate risk-adjusted return. In comparison, peers DRREDDY and DIVISLAB underperformed with negative returns, while HINDUNILVR returned a modest 0.98%. Overall, SUNPHARMA's performance was impressive, but its Max Drawdown of -0.87% suggests some risk was involved.

[Volatility: 25.17%]